<DOC>
	<DOCNO>NCT00822900</DOCNO>
	<brief_summary>The ProTECT study determine intravenous ( IV ) progesterone ( start within 4 hour injury give total 96 hour ) , effective placebo treat victim moderate severe acute traumatic brain injury .</brief_summary>
	<brief_title>Progesterone Treatment Traumatic Brain Injury III</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Soybean oil , phospholipid emulsion</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Moderate severe brain injury ( GCS 124 ) Age 18 year old Blunt , close head injury Study drug initiate within 4 hour injury NonSurvivable injury Bilateral dilate unresponsive pupil Severe intoxication ( ETOH &gt; 250 mg % ) Spinal cord injury neurological deficit Inability perform activity daily live prior injury Cardiopulmonary arrest Status epilepticus arrival Systolic blood pressure ( SBP ) &lt; 90 arrival least 5 minute prior enrollment O2 Sat &lt; 90 arrival least 5 minute prior enrollment Prisoner ward state Pregnant Active breast reproductive organ cancer Known allergy progesterone intralipid component ( egg yolk ) Known history clot disorder Active thromboembolic event Concern inability follow 6 month Anyone list Opt registry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Trauma</keyword>
	<keyword>Brain Injury</keyword>
</DOC>